All data are based on the daily closing price as of September 30, 2026
h

Hanmi Science Co.

008930.KO
39.02 USD
0.55
+1.43%

Overview

Last close
39.02 usd
Market cap
2.64B usd
52 week high
43.06 usd
52 week low
17.00 usd
Target price
23.93 usd

Valuation

P/E
N/A
Forward P/E
N/A
Price/Sales
2.5405
Price/Book Value
3.3268
Enterprise Value
2.67B usd
EV/Revenue
2.5672
EV/EBITDA
18.447

Key financials

Revenue TTM
1.04B usd
Gross Profit TTM
246.34M usd
EBITDA TTM
56.42M usd
Earnings per Share
N/A usd
Dividend
0.22 usd
Total assets
990.35M usd
Net debt
54.56M usd

About

Hanmi Science Co., Ltd., through its subsidiaries, manufactures and sells pharmaceutical products in Korea and internationally. It develops drugs in the areas of diabetes and anti-cancer, as well as children's and adult's bowel preparation and cold medicines, and cephalosporin antibiotics. The company also offers general foods, health functional foods, soy milk, and medical equipment. In addition, it offers automated drug management systems. The company sells its products through online and offline pharmacies. The company was formerly known as Hanmi Holdings Co., Ltd. and changed its name to Hanmi Science Co., Ltd. in March 2012. Hanmi Science Co., Ltd. was founded in 1973 and is headquartered in Seoul, South Korea.
  • Symbol
    008930.KO
  • Exchange
    KO
  • Isin
    KR7008930000
  • Country
    South Korea
  • Sector
    Healthcare
  • Industry
    Medical Distribution
  • CEO
    Mr. Lim Chong-Yoon
  • Headquarter
    Seoul
  • Web site
    https://www.hanmiscience.co.kr
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top